Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance

Authors :: Staci Horvath
Minal A. Barve
Neil Senzer
Johnathan Oh
Phylicia Aaron
Laura Stanbery
Rodney P. Rocconi
Meghan Manley
Ernest Bognar
Luisa Manning
Adam Walter
Gladice Wallraven
John Nemunaitis
Source :: Gynecologic Oncology Reports, Gynecologic Oncology Reports, Vol 34, Iss, Pp 100648-(2020)
Publication Year :: 2020
Publisher :: Elsevier, 2020.

Subjects :: Vigil
Advanced ovarian cancer
Pediatrics
medicine.medical_specialty
business.industry
Long term follow up
MEDLINE
Obstetrics and Gynecology
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Phase (combat)
lcsh:Gynecology and obstetrics
lcsh:RC254-282
Oncology
Correspondence
Medicine
business
lcsh:RG1-991

Tools